Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7RCT

Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor RMC-4550

Summary for 7RCT
Entry DOI10.2210/pdb7rct/pdb
DescriptorTyrosine-protein phosphatase non-receptor type 11, {3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl}methanol, CHLORIDE ION, ... (4 entities in total)
Functional Keywordsshp2 rmc-4550 phosphatase, signaling protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight121441.55
Authors
Seegar, T.C.M. (deposition date: 2021-07-08, release date: 2021-09-01, Last modification date: 2024-10-09)
Primary citationVemulapalli, V.,Donovan, K.A.,Seegar, T.C.M.,Rogers, J.M.,Bae, M.,Lumpkin, R.J.,Cao, R.,Henke, M.T.,Ray, S.S.,Fischer, E.S.,Cuny, G.D.,Blacklow, S.C.
Targeted Degradation of the Oncogenic Phosphatase SHP2.
Biochemistry, 60:2593-2609, 2021
Cited by
PubMed Abstract: SHP2 is a protein tyrosine phosphatase that plays a critical role in the full activation of the Ras-MAPK pathway upon stimulation of receptor tyrosine kinases, which are frequently amplified or mutationally activated in human cancer. In addition, activating mutations in SHP2 result in developmental disorders and hematologic malignancies. Several allosteric inhibitors have been developed for SHP2 and are currently in clinical trials. Here, we report the development and evaluation of a SHP2 PROTAC created by conjugating RMC-4550 with pomalidomide using a PEG linker. This molecule is highly selective for SHP2, induces degradation of SHP2 in leukemic cells at submicromolar concentrations, inhibits MAPK signaling, and suppresses cancer cell growth. SHP2 PROTACs serve as an alternative strategy for targeting ERK-dependent cancers and are useful tools alongside allosteric inhibitors for dissecting the mechanisms by which SHP2 exerts its oncogenic activity.
PubMed: 34411482
DOI: 10.1021/acs.biochem.1c00377
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

236371

PDB entries from 2025-05-21

PDB statisticsPDBj update infoContact PDBjnumon